Tri-specific T cell engager therapy(Lepu Biotech)

三特异性T细胞衔接器（乐普生物）

Report date: 2024/03/08 17:52:42

Base Information

Drug NameTri-specific T cell engager therapy(Lepu Biotech)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLepu Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLepu Biopharma Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A